Nextremity Touts Success With New Strategy

Posted: Updated:
The InCore Lapidus System, an orthopedic device for the foot, contributed to sales momentum in 2018. The InCore Lapidus System, an orthopedic device for the foot, contributed to sales momentum in 2018.

Warsaw-based Nextremity Solutions, Inc. says 2018 was a critical year of validation. The orthopedic company changed its business model in 2016—moving away from its roots as a traditional startup and becoming a strategic commercialization organization. Nextremity leaders say the shift was a success; the company recently ranked 331st on Deloitte’s Technology Fast 500 with a 246 percent revenue growth rate.

While taking leaps forward, Nextremity executives say the company’s strategy still centers on its visionaries: orthopedic surgeons. Dr. Lon Weiner and Dr. Stuart Katchis—both in New York City—co-founded the startup in 2007 by identifying unmet needs in the operating room. Nextremity Chief Technology Officer Ryan Schlotterback says the team took the surgeons’ East Coast ideas and brought them to the fertile soil of the Orthopedic Capital of the World in 2013.

“There’s huge value [being in Warsaw],” says Schlotterback. “Since 2016, our strategy is to develop products and deliver those to the large strategic OEMs. And here in Warsaw, there are some of the biggest; it works really well to be local and close to them.”

Nextremity specializes in foot and ankle implants, which are among the fastest-growing areas in orthopedics. When the young company shifted its business model in 2016, Schlotterback says it desired something different than a traditional product development or fee-for-service company.

“So we landed somewhere in the middle,” says Schlotterback. “Today, we’re a strategic commercialization organization where we develop products and take them to the market, with all of the traditional marketing collaterals and sales tools. We prove those products out, then we turn those over to one of the large strategic companies to take it more fully into the market and around the globe.”

Nextremity leaders say the shift—and the successful partnerships that have come along with it—opened the door to the exponential growth that landed the company on Deloitte’s Technology Fast 500. Product launches in 2018, such as the InCore Lapidus System, an orthopedic device for the foot, also contributed to sales momentum. 

“[Our products] are very different than what’s on the market. We’re focused on developing products that allow the surgeon to have reproduceable outcomes and really stable constructs,” says Schlotterback. “All of our products—whether it’s for hammertoe or bunions—approach those [conditions] from a different angle that’s unlike what else is on the market.”

Nextremity says its i3 Strategic Solutions team executes a process flow called micro-commercialization, which is “the heart of what we’re doing.” Schlotterback says the “more wholistic approach” centers on surgeons, streamlining product development to ensure their ideas are commercialized and, ultimately, help patients.

Nextremity has commercialized seven products; the eighth has earned regulatory clearance and will be launching soon. The company, now with 18 employees, says it has a very strong pipeline and expects to commercialize two or more products this year.

With innovations conceived by surgeons and ultimately used by them, Schlotterback says Nextremity has settled into its sweet spot—filling the gap in the middle.

“Nextremity is best suited to keep delivering value to our shareholders by continuing to develop products and solutions to the market and, ultimately, to our strategic partners,” says Schlotterback. “If we do that, the rest will take care of itself.”

Schlotterback says Nextremity’s partnership with a large orthopedic company opens the door to global markets.
Schlotterback says shifting Nextremity’s business model in 2016 allowed it to focus on what it does best.
  • Perspectives

    • World Refugee Day Shines Light on Untapped Pool of Talented Workers

      From Fortune 500 companies to local small businesses, a similar theme rings true. In this strong economy where unemployment is low and growth is high, companies are competing for top talent. In Indianapolis - according to the U.S. Bureau of Labor and Statistics - unemployment is just 2.8 percent, and investment and job growth are on the rise. This is great news for Indianapolis-area residents looking for work or opportunities to advance their careers, but for businesses and...


Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • Lilly Exec Named BioCrossroads CEO

      After a national search, BioCrossroads has announced Patty Martin will become the life science initiative's next president and chief executive officer. Martin, who most recently served as chief operating officer for Lilly Diabetes, will begin her new role Monday. She will become just the third CEO in the organization's 17-year history, and succeeds David Johnson, who in December announced plans to step down from the role to serve as president and CEO of the...

    • (file photo courtesy of Radial)

      Radial Opens Fulfillment Center in Brownsburg

      Pennsylvania-based Radial Inc. says its new fulfillment center in Brownsburg is now open. The e-commerce technology and operations company says the nearly 700,000-square-foot facility is the largest in its network and will have the capacity to house about 2,000 employees.

    • Holcomb will chair the 2019 conference, set for November 7 in Indianapolis.

      Janet Holcomb to Chair Conference For Women

      Indiana First Lady Janet Holcomb will serve as chair for this year's Indiana Conference for Women. Nearly 2,000 people are expected to attend the ninth annual conference, in Indianapolis in November. Holcomb's career includes a stint as vice president of her family's bolt and fastener manufacturing business, R&R Engineering. She has also led fundraising efforts for political campaigns as well as nonprofit organizations focusing in areas including animal welfare, arts and...

    • (rendering courtesy of Jones Development Co.)

      New Business Park Planned for Whiteland

      Missouri-based Jones Development Co. has begun construction on a new business park in Johnson County. The 2.4 million-square-foot Whiteland Exchange will be located on 167 acres near I-65 in Whiteland.  Financial terms of the developer's investment in the project were not disclosed. The business park is slated to include modern industrial buildings for logistics, advanced manufacturing and related uses. Work is underway on the first two speculative buildings, which total nearly...

    • Franciscan Health Details Data Breach

      Mishawaka-based Franciscan Health is providing details of a data breach. The health system says an internal investigation found one of its employees accessed the protected health information of about 2,200 patients "without a business reason."  Franciscan says the vast majority of the affected medical records was limited to demographic information such as name, address, email address, date of birth, phone number, gender, race/ethnicity, the last four digits of...